Journal of Psychopharmacology

Article	Citations
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up	161
Ketamine: A tale of two enantiomers	104
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science	97
Pivotal mental states	70
Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD	65
Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca	63
Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis	56
First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder	55
Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin	55
A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers	51
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches	50
Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium	50
Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience	49
Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review	48
Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial	41
Associations between lifetime classic psychedelic use and markers of physical health	41
Acute subjective effects in LSD- and MDMA-assisted psychotherapy	40
Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review	40
Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans	39
Does cannabis complement or substitute alcohol consumption? A systematic review of human and animal studies	38
Psychedelics and health behaviour change	38
The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration an	38
Modulation of microglial activation by antidepressants	37
Dose–response relationships of psilocybin-induced subjective experiences in humans	36
Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial	35

Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology	33
A qualitative and quantitative account of patient’s experiences of ketamine and its antidepressant properties	33
Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study	32
Assessment of cognitive and psychomotor impairment, subjective effects, and blood THC concentrations following acute administration of oral and vaporized cannabis	32
Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action	31
The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects	30
A narrative synthesis of research with 5-MeO-DMT	29
Prediction of MDMA response in healthy humans: a pooled analysis of placebo-controlled studies	28
Neurobiological mechanisms associated with antipsychotic drug-induced dystonia	28
Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?	27
MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults	27
Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals	27
Medical cannabis in the UK: From principle to practice	26
Efficacy ofN-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials	26
Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings	25
Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice	24
Pharmacological treatment of acute-phase anorexia nervosa: Evidence from randomized controlled trials	23
Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca	23
Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention	23
Rates of delirium associated with calcium channel blockers compared to diuretics, renin-angiotensin system agents and beta-blockers: An electronic health records network study	23
A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis	23
Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes	23
Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms	22
Efficacy of antidepressant drugs in the treatment of depression in Alzheimer disease patients: A systematic review and network meta-analysis	22
Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy	22
The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: An arterial spin labelling magnetic resonance imaging study	22
Effects of omega-3 polyunsaturated fatty acids supplements on psychopathology and metabolic parameters in schizophrenia: A meta-analysis of randomized controlled trials	22
Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial	22
One (effect) size does not fit at all: Interpreting clinical significance and effect sizes in depression treatment trials	22
Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer’s disease: Machine learning approaches	22
Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports	21
Cannabis based medicines and cannabis dependence: A critical review of issues and evidence	21
Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis	21
Investigating the effect of crocin on memory deficits induced by total sleep deprivation (TSD) with respect to the BDNF, TrkB and ERK levels in the hippocampus of male Wistar rats	21
The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility	20
Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample	20
A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults	19
An acetylcholinesterase inhibitor, donepezil, increases anxiety and cortisol levels in adult zebrafish	19
Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997–2019	18
Point-of-care measurement of clozapine concentration using a finger-stick blood sample	18
Cannabidiol modulation of hippocampal glutamate in early psychosis	18
Effects of repeated adolescent exposure to cannabis smoke on cognitive outcomes in adulthood	18
Fifty years on: Serotonin and depression	17
Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice	17
Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression	16
Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity	16
LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking	16
Rodent models for nicotine withdrawal	16
Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment	16
Efficacy and tolerability of pharmacological interventions on metabolic disturbance induced by atypical antipsychotics in adults: A systematic review and network meta-analysis	16

Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension	16
Cannabis-induced oceanic boundlessness	16
Sign tracking predicts cue-induced but not drug-primed reinstatement to methamphetamine seeking in rats: Effects of oxytocin treatment	16
Hyodeoxycholic acid inhibits lipopolysaccharide-induced microglia inflammatory responses through regulating TGR5/AKT/NF-κB signaling pathway	16
Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania	15
A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression	15
Glutamatergic and GABAergic reactivity and cognition in 22q11.2 deletion syndrome and healthy volunteers: A randomized double-blind 7-Tesla pharmacological MRS study	14
Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)	14
Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology	14
Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: A systematic review	14
Two newly-emerging substituted phenethylamines MAL and BOD induce differential psychopharmacological effects in rodents	14
The acute effects of cannabidiol on the neural correlates of reward anticipation and feedback in healthy volunteers	14
Increasing recreational nitrous oxide use: Should we worry? A narrative review	14
Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate	14
AMPA receptors mediate the pro-cognitive effects of electrical and optogenetic stimulation of the medial prefrontal cortex in antidepressant non-responsive Wistar–Kyoto rats	14
Neural mechanisms underlying psilocybin’s therapeutic potential – the need for preclinical in vivo electrophysiology	14
Naturalistic use of psychedelics is related to emotional reactivity and self-consciousness: The mediating role of ego-dissolution and mystical experiences	13
Activation of the aryl hydrocarbon receptor by clozapine induces preadipocyte differentiation and contributes to endothelial dysfunction	13
Development and validation of the Reward Deficiency Syndrome Questionnaire (RDSQ-29)	13
Effects of subcutaneous esketamine on blood pressure and heart rate in treatment-resistant depression	13
Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: Preliminary evidence in adolescents with treatment-resistant depression	13
Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study	13
Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms	13
Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis	13
Sex-dependent metabolism of ketamine and (2R,6R)-hydroxynorketamine in mice and humans	13
Effects on suicidal risk: Comparison of clozapine to other newer medicines indicated to treat schizophrenia or bipolar disorder	12
Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 µg LSD in healthy participants within a novel intervention paradigm: A proof-of-concept study	12
Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze	12
Pharmacological evidence of a cholinergic contribution to elevated impulsivity and risky decision-making caused by adding win-paired cues to a rat gambling task	12
Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: A systematic review of the literature	12
The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment	12
Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption	12
Oxytocin-induced facilitation of learning in a probabilistic task is associated with reduced feedback- and error-related negativity potentials	12
Clinical validation of the self-reported Glasgow Antipsychotic Side-effect Scale using the clinician-rated UKU side-effect scale as gold standard reference	12
Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study	11
Sex-specific sensitivity to methamphetamine-induced schizophrenia-relevant behaviours in neuregulin 1 type III overexpressing mice	11
Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice	11
Effects of acute alcohol consumption on emotion recognition in high and low trait aggressive drinkers	11
Pharmacological uses of flumazenil in benzodiazepine use disorders: a systematic review of limited data	11
Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers	11
Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016	11
Nitric oxide-mediated defensive and antinociceptive responses organised at the anterior hypothalamus of mice are modulated by glutamatergic inputs from area 24b of the cingulate cortex	11
MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinde	11
CB1 receptor signalling mediates cannabidiol-induced panicolytic-like effects and defensive antinociception impairment in mice threatened by Bothrops jararaca lancehead pit vipers	11
Lithium exposure during pregnancy increases fetal growth	11
The effect of metformin on cognitive function: A systematic review and meta-analysis	11
The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls	11
Differential modulation of the contextual conditioned emotional response by CB1 and TRPV1 receptors in the ventromedial prefrontal cortex: Possible involvement of NMDA/nitric oxide-related mechanisms	10
Belief changes associated with psychedelic use	10
Neuropsychological performance in young adults with cannabis use disorder	10
The effects of reserpine on depression: A systematic review	10
Effects of clozapine treatment on the improvement of substance use disorders other than nicotine in individuals with schizophrenia spectrum disorders: A systematic review and meta-analysis	10
Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use	10
Mice lacking melatonin MT2 receptors exhibit attentional deficits, anxiety and enhanced social interaction	10
Time-dependent association between selective serotonin reuptake inhibitors and hospitalization due to hyponatremia	10
Emotional faces processing in major depressive disorder and prediction of antidepressant treatment response: A NeuroPharm study	10
Cardiovascular effects of repeated subanaesthetic ketamine infusion in depression	10
The neurobiology of suicide in psychosis: A systematic review	10
Risk of incident dementia in late-life depression treated with antidepressants: A nationwide population cohort study	10
Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration–effect relations using the IB-de-risk tool	10
Intranasal oxytocin may help maintain romantic bonds by decreasing jealousy evoked by either imagined or real partner infidelity	10
Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data	10
β-adrenoceptor antagonists and nightmares: A pharmacoepidemiological–pharmacodynamic study	10
The pharmacogenetics of opioid treatment for pain management	10
The µ-opioid system in midline thalamic nuclei modulates defence strategies towards a conditioned fear stimulus in male mice	10
The effects of atorvastatin on emotional processing, reward learning, verbal memory and inflammation in healthy volunteers: An experimental medicine study	9
Antidepressant-like effect of tofisopam in mice: A behavioural, molecular docking and MD simulation study	9
Sustained NMDA receptor hypofunction impairs brain-derived neurotropic factor signalling in the PFC, but not in the hippocampus, and disturbs PFC-dependent cognition in mice	9
Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020	9
Sex differences in nicotine-induced impulsivity and its reversal with bupropion in rats	9
Antidepressant responses in direct comparisons of melancholic and non-melancholic depression	9
Clinical validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview	9
Individual and combined effects of cannabidiol and Δ9-tetrahydrocannabinol on striato-cortical connectivity in the human brain	9
Discontinuation and relapse with paliperidone palmitate three-monthly for maintenance of schizophrenia: Two year follow-up of use in clinical practice	9
Challenges in translational research: MDMA in the laboratory versus therapeutic settings	9
The recognition and management of protracted alcohol withdrawal may improve and modulate the pharmacological treatment of alcohol use disorder	9
Association of the OPRM1 A118G polymorphism and Pavlovian-to-instrumental transfer: Clinical relevance for alcohol dependence	9
To BDZ or not to BDZ? That is the question! Is there reliable scientific evidence for or against using benzodiazepines in the aftermath of potentially traumatic events for the prevention of PTSD? A sy	9
Perceived harm, motivations for use and subjective experiences of recreational psychedelic ‘magic’ mushroom use	9
The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial	9

A unified model of ketamine’s dissociative and psychedelic properties	9
Clinical effects of glabellar botulinum toxin injections on borderline personality disorder: A randomized controlled trial	9
The history of clozapine in clinical practice: From its introduction to a guideline proposing personalized titrations	8
Examining the role of systemic chronic inflammation in diet and sleep relationship	8
The innate immune system and neurogenesis as modulating mechanisms of electroconvulsive therapy in pre-clinical studies	8
Accuracy in recognising happy facial expressions is associated with antidepressant response to a NOP receptor antagonist but not placebo treatment	8
Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA	8
Temporal dissociation of phencyclidine: Induced locomotor and social alterations in rats using an automated homecage monitoring system – implications for the 3Rs and preclinical drug discovery	8
Higher venlafaxine serum concentrations necessary for clinical improvement? Time to re-evaluate the therapeutic reference range of venlafaxine	8
Altered cerebellar-cortical resting-state functional connectivity in cannabis users	8
The role of the mTOR pathway in models of drug-induced reward and the behavioural constituents of addiction	8
Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid live	8
The antidepressant effect and safety of non-intranasal esketamine: A systematic review	8
Psilocybin history, action and reaction: A narrative clinical review	8
Attenuation of antidepressive effects of transcranial magnetic stimulation in patients whose medication includes drugs for psychosis	8
Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression	8
Effect of antidepressant drugs on the brain sphingolipid system	8
Regulation of clock and clock-controlled genes during morphine reward and reinforcement: Involvement of the period 2 circadian clock	8
Methylenedioxymethamphetamine-like discriminative stimulus effects of pyrrolidinyl cathinones in rats	8
Preliminary evidence for the phosphodiesterase type-4 inhibitor, roflumilast, in ameliorating cognitive flexibility deficits in patients with schizophrenia	8
Paternal exposure to morphine during adolescence potentiates morphine withdrawal in male offspring: Involvement of the lateral paragigantocellularis nucleus	8
A theory of the anxiolytic action of flumazenil in anxiety disorders	8
Orexin-1 receptor signaling within the lateral hypothalamus, but not bed nucleus of the stria terminalis, mediates context-induced relapse to alcohol seeking	8
Selective activation of D1 dopamine receptors exerts antidepressant-like activity in rats	7
Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes	7
Enhanced responsiveness to hypoxic panicogenic challenge in female rats in late diestrus is suppressed by short-term, low-dose fluoxetine: Involvement of the dorsal raphe nucleus and the dorsal periaq	7
Dopaminergic and noradrenergic modulation of stress-induced alterations in brain activation associated with goal-directed behaviour	7
Efficacy and safety of supraphysiologic doses of levothyroxine for patients with bipolar depression in adults: A systematic review	7
Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series	7
Incident infection during the first year of treatment – A comparison of clozapine and paliperidone palmitate long-acting injection	7
URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vani	7
Efficacy of onabotulinumtoxinA in the treatment of unipolar major depression: Systematic review, meta-analysis and meta-regression analyses of double-blind randomised controlled trials	7
Evidence for the atherogenic index of plasma as a potential biomarker for cardiovascular disease in schizophrenia	7
Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capacity Building Group	7
Alprazolam-related deaths in Scotland, 2004–2020	7
Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy—A systematized review	7
A Bayesian meta-analysis of topiramate’s effectiveness for individuals with alcohol use disorder	7
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors	7
β-carboline-independent antidepressant-like effect of the standardized extract of the barks of Mimosa tenuiflora (Willd) Poir. occurs via 5-HT2A/2C receptors in mice	7
Effects of caffeine on ethanol-elicited place preference, place aversion and ERK phosphorylation in CD-1 mice	7
Visualizing classification of drugs used in psychotic disorders: A ‘subway map’ representing mechanisms, established classes and informal categories	7
Isoginkgetin treatment attenuated lipopolysaccharide-induced monoamine neurotransmitter deficiency and depression-like behaviors through downregulating p38/NF-κB signaling pathway and suppressing micr	7
Antipsychotics in routine treatment are minor contributors to QT prolongation compared to genetics and age	7
Starting lithium in patients with compromised renal function – is it wise?	7
Differences in social brain function in autism spectrum disorder are linked to the serotonin transporter: A randomised placebo-controlled single-dose crossover trial	7
Pharmacological treatment for Tourette syndrome in children and adults: What is the quality of the evidence? A systematic review	7
Insufficiency of ventral hippocampus to medial prefrontal cortex transmission explains antidepressant non-response	7
Effect of selective serotonin reuptake inhibitor discontinuation on anxiety-like behaviours in mice	7
High dose antipsychotic polypharmacy and dopamine partial agonists - time to rethink guidelines?	6
Contrasting effects of the α7 nicotinic receptor antagonist methyllycaconitine in different rat models of heroin reinstatement	6
A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression	6
Regular cannabis use modulates the impact of HIV on the neural dynamics serving cognitive control	6
The risk of chronic psychedelic and MDMA microdosing for valvular heart disease	6
State anxiety and alcohol choice: Evidence from experimental and online observational studies	6
Postpartum psychosis: A proposed treatment algorithm	6
Voluntary oral methamphetamine increases memory deficits and contextual sensitization during abstinence associated with decreased PKMζ and increased κOR in the hippocampus of female mice	6
Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia	6
Reduced risk for hospitalization due to hyponatraemia in lithium treated patients: A Swedish population-based case–control study	6
A clinical method of evaluating simple reaction time and reaction accuracy is sensitive to a single dose of lorazepam	6
Glyceryl trinitrate in first-episode psychosis unmedicated with antipsychotics: A randomised controlled pilot study	6
Connected to the spirit of the frog: An Internet-based survey on Kambô, the secretion of the Amazonian Giant Maki Frog (Phyllomedusa bicolor): Motivations for use, settings and subjective exper	6
Assessment of the neuronal underpinnings of cognitive impairment in bipolar disorder with a picture encoding paradigm and methodological lessons learnt	6
The influence of stimulus onset asynchrony, task order, sex and hormonal contraception on prepulse inhibition and prepulse facilitation: Methodological considerations for drug and imaging research	6
Disentangling the effects of cannabis and cigarette smoking on impulsivity	6
Relationship between depression, prefrontal creatine and grey matter volume	6
The effect of the AKT1 gene and cannabis use on cognitive performance in healthy subjects	5
Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder	5
Long-term administration of cariprazine increases locus coeruleus noradrenergic neurons activity and serotonin1A receptor neurotransmission in the hippocampus	5
Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective	5
Projection-specific dopamine neurons in the ventral tegmental area participated in morphine-induced hyperalgesia and anti-nociceptive tolerance in male mice	5
Psilocybin’s effects on cognition and creativity: A scoping review	5
Effect of liraglutide on neural and peripheral markers of metabolic function during antipsychotic treatment in rats	5
Selective effects of serotonin on choices to gather more information	5
Profile of a short-acting κ-antagonist, LY2795050, on self-grooming behaviors, forced swim test and locomotor activity: sex comparison in mice	5
Hydrocortisone as an adjunct to brief cognitive-behavioural therapy for specific fear: Endocrine and cognitive biomarkers as predictors of symptom improvement	5
Association study of BDNF Val66Met gene polymorphism with bipolar disorder and lithium treatment response in Indian population	5
Selective attention to emotional stimuli and emotion recognition in patients with major depression: The role of mineralocorticoid and glutamatergic NMDA receptors	5
Increasing dietary choline attenuates spatial memory deficits resulting from exposure to the chemotherapeutic agents cyclophosphamide and doxorubicin	5
Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine	5
The New Zealand drug harms ranking study: A multi-criteria decision analysis	5
Effects of benzodiazepine and orexin receptor antagonist on cognitive function revealed by auditory event-related potentials	5
Individual differences in cocaine-induced conditioned place preference in male rats: Behavioral and transcriptomic evidence	5
Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide in healthy participants within a novel intervention paradigm: Qualitative results from a	5
Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophrenia	5
Blockade of D3 receptor prevents changes in DAT and D3R expression in the mesolimbic dopaminergic circuit produced by social stress- and cocaine prime-induced reinstatement of cocaine-CPP	5
Subjective executive function deficits in hazardous alcohol drinkers	5
Effect of CannEpil® on simulated driving performance and co-monitoring of ocular activity: A randomised controlled trial	5
Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review	5
A phase 1 study to assess potential interaction between ASP8062 and alcohol in healthy adult subjects	5
Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial	5
Efficacy and safety of brexpiprazole in patients with schizophrenia presenting with severe symptoms: Post-hoc analysis of short- and long-term studies	5
Patient perspectives of lithium and quetiapine augmentation treatment in treatment-resistant depression: A qualitative assessment	5
Anxiolytic effects of acute and maintenance ketamine, as assessed by the Fear Questionnaire subscales and the Spielberger State Anxiety Rating Scale	5
We need to talk: The urgent conversation on chronic pain, mental health, prescribing patterns and the opioid crisis	4
Histamine 3 receptor inverse agonist Samelisant (SUVN-G3031): Pharmacological characterization of an investigational agent for the treatment of cognitive disorders	4